SEC Tracker
Get the app

Pacira BioSciences PCRX

Pacira BioSciences: announces exit or restructuring costs and makes a Regulation FD disclosure

Form
8-K
Filed
Importance
Routine
  • Announces exit or restructuring costs (2.05)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Pacira BioSciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  2. uniQure QURE public float $765M, Jun 30, 2025
  3. Cogent Biosciences COGT public float $773M, Jun 30, 2025
  4. Immunome IMNM public float $729M, Jun 30, 2025
  5. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025